Correlation Between Tekla Healthcare and Gmo Emerging

Can any of the company-specific risk be diversified away by investing in both Tekla Healthcare and Gmo Emerging at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tekla Healthcare and Gmo Emerging into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tekla Healthcare Opportunities and Gmo Emerging Markets, you can compare the effects of market volatilities on Tekla Healthcare and Gmo Emerging and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tekla Healthcare with a short position of Gmo Emerging. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tekla Healthcare and Gmo Emerging.

Diversification Opportunities for Tekla Healthcare and Gmo Emerging

0.7

Correlation Coefficient

Tekla Healthcare  Gmo Emerging

Poor diversification

The 3 months correlation between Tekla and Gmo is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Tekla Healthcare Opportunities and Gmo Emerging Markets in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gmo Emerging Markets and Tekla Healthcare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tekla Healthcare Opportunities are associated (or correlated) with Gmo Emerging. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gmo Emerging Markets has no effect on the direction of Tekla Healthcare i.e., Tekla Healthcare and Gmo Emerging go up and down completely randomly.

Pair Corralation between Tekla Healthcare and Gmo Emerging

Considering the 90-day investment horizon Tekla Healthcare Opportunities is expected to under-perform the Gmo Emerging. In addition to that, Tekla Healthcare is 1.35 times more volatile than Gmo Emerging Markets. It trades about -0.11 of its total potential returns per unit of risk. Gmo Emerging Markets is currently generating about 0.02 per unit of volatility. If you would invest  2,464  in Gmo Emerging Markets on September 13, 2024 and sell it today you would earn a total of  22.00  from holding Gmo Emerging Markets or generate 0.89% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Tekla Healthcare Opportunities  vs.  Gmo Emerging Markets

Tekla Healthcare Opp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Tekla Healthcare Opportunities has generated negative risk-adjusted returns adding no value to fund investors. Even with latest inconsistent performance, the Fund's technical indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the fund retail investors.

Gmo Emerging Markets

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Gmo Emerging Markets are ranked lower than 1 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong basic indicators, Gmo Emerging is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Tekla Healthcare and Gmo Emerging

The main advantage of trading using opposite Tekla Healthcare and Gmo Emerging positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tekla Healthcare position performs unexpectedly, Gmo Emerging can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gmo Emerging will offset losses from the drop in Gmo Emerging's long position.

The idea behind Tekla Healthcare Opportunities and Gmo Emerging Markets pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.